Efficacy of the combined therapy with Rituximab plus Cyclophosphamide versus Cyclophosphamide as Monotherapy in Systemic Sclerosis-Associated Interstitial Lung Disease

被引：0
|
作者：
Tejeda-Andrade, C. F. [1 ]
Villalpando-Gomez, Y. [1 ]
Gamez-Nava, J., I [1 ]
Castro-Lizano, N. [1 ]
Rocha-Munoz, A. D. [1 ]
Cardona, Munoz E. G. [1 ]
Gonzalez-Lopez, L. [1 ]
机构：
[1] Univ Guadalajara, CUCS, Unidad Invest Cardiovasc, Guadalajara, Jalisco, Mexico
来源：
JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1193 / 1193
页数：1
相关论文
共 50 条
  • [41] Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
    Chung, Jonathan H.
    Walker, Christopher M.
    Hobbs, Stephen
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (160): : na
  • [42] Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease REPLY
    Distler, Oliver
    Gahlemann, Martina
    Maher, Toby M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16): : 1596 - 1597
  • [43] Personalized Medicine for Systemic Sclerosis-Associated Interstitial Lung Disease
    Ma, Angela
    Montesi, Sydney B.
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2025, 11 (01)
  • [44] Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease
    Ebata, S.
    Yoshizaki, A.
    Fukasawa, T.
    Nakamura, K.
    Yamashita, T.
    Miura, S.
    Saigusa, R.
    Ichimura, Y.
    Takahashi, T.
    Hirabayashi, M.
    Taniguchi, T.
    Akamata, K.
    Asano, Y.
    Sato, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (03) : 247 - 249
  • [45] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Athanasios Koutroumpas
    Athanasios Ziogas
    Ioannis Alexiou
    Georgia Barouta
    Lazaros I. Sakkas
    Clinical Rheumatology, 2010, 29 : 1167 - 1168
  • [46] Efficacy of Mycophenolate Associated with Methotrexate as a Maintenance Treatment for Systemic Sclerosis-Associated Interstitial Lung Disease
    Antonio Gonzalez-Nieto, Jose
    Javier Martin-Suarez, Ignacio
    Luis Gil-Munoz, Francisco
    ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (11): : 575 - 575
  • [47] Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease
    Atanelishvili, I.
    Akter, T.
    Noguchi, A.
    Vuyiv, O.
    Wollin, L.
    Silver, R. M.
    Bogatkevich, G. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (04) : S115 - S124
  • [48] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Koutroumpas, Athanasios
    Ziogas, Athanasios
    Alexiou, Ioannis
    Barouta, Georgia
    Sakkas, Lazaros I.
    CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1167 - 1168
  • [49] Responses to exercise in systemic sclerosis-associated interstitial lung disease
    Donnelly, Ronan P.
    Smyth, Anita E.
    Mullan, Charles
    Riley, Marshall S.
    Nicholls, D. Paul
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2023, 43 (04) : 253 - 262
  • [50] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
    Yamasaki, Yoshioki
    Kuwana, Masataka
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
12345